Weight Implements to Improve Throwing Speed and Shoulder Mobility in Baseball Pitchers

September 1, 2021 updated by: Investigación en Hemofilia y Fisioterapia

Efficacy of a Physiotherapy Intervention by Means of Weight Implements in the Improvement of Throwing Speed and Shoulder Mobility in Baseball Pitchers. A Randomized Pilot Study.

Increasing the speed of pitches is key in baseball performance. The interventions by means of the implement of weights are used to improve the strength and to strengthen the muscles of the shoulder.

The objective of the study is to assess the effectiveness of an exercise protocol with weight implements in increasing the speed of throws and shoulder mobility in pitchers aged 18 to 40 years.

Randomized pilot study. 12 pitchers will be randomized to the study groups: experimental (intervention with launches with weight implement) and control (without any intervention). The intervention will last 4 weeks, with 2 weekly sessions of 15 minutes each. The study variables will be the range of shoulder movement (goniometry) and the speed of the throws (speed radar). A descriptive statistical analysis will be performed calculating median and interquartile range. With the Shapiro-Wills test, the sample distribution will be calculated. If there is homogeneity, with the t-student test the changes will be calculated after the intervention in both groups. The intra and intersubject effect will be calculated with the ANOVA of repeated measures. The effect size will be obtained with Cohen's mean difference formula.

It is expected to see improvement in the speed of the throws and in the range of shoulder movement.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Comunity Of Madrid
      • Madrid, Comunity Of Madrid, Spain, 28670
        • Universidad Europea de Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male baseball pitchers
  • With an age range of 18 to 40 years
  • With more than three years of sports practice as a pitcher
  • That currently practice in regional or professional competitions

Exclusion Criteria:

  • Subjects who have undergone some surgery on the dominance arm with which they launch in the last 12 months
  • Who are receiving a specific shoulder mobility intervention
  • Have not signed the informed consent document

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental group

Each session will last 15 minutes, taking place for 2 days a week, over a period of 4 weeks. The intervention will take place at the beginning of the training session.

Prior to training, each pitcher will perform his normal warm-up routine, notifying the investigator when he feels ready to perform the training. The intervention through weight implements will consist in the application of the protocol described by Fleising et al. The objective of the application of the technique is to produce an increase in the speed of the throws.

The technique will be done by making the same movement of the launch, but with the weight implement. The physiotherapist will be next to the pitcher, noting that there is no pain or discomfort when launching. The session will be held for 15min with 30 seconds of rest between each launch, until reaching 15 pitches.

The sessions will be directed by a physiotherapist, in charge of supervising that the pitcher is correctly making the requested movement.

NO_INTERVENTION: Control group
Athletes included in the control group will conduct their training and activities on a daily basis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline internal shoulder rotation after treatment and at month
Time Frame: Screening visit, within the first seven days after treatment and after one month follow-up visit
A goniometer will be used to measure the range of shoulder joint mobility. The athlete will be placed supine with the shoulder in 90º of abduction and the elbow flexed to 90º. The patient will be asked to do an internal shoulder rotation. The goniometer axis will be placed on the olecranon, while the mobile arm aligned along the cube to the ulnar process and the fixed arm will be perpendicular to the ground. The unit of measure is the degrees; where to greater graduation, greater mobility. The normative range of shoulder mobility is 0º-70º in internal rotation.
Screening visit, within the first seven days after treatment and after one month follow-up visit
Change from baseline external shoulder rotation after treatment and at month
Time Frame: Screening visit, within the first seven days after treatment and after one month follow-up visit
A goniometer will be used to measure the range of shoulder joint mobility. The athlete will be placed supine with the shoulder in 90º of abduction and the elbow flexed to 90º. The patient will be asked to do an external shoulder rotation. The goniometer axis will be placed on the olecranon, while the mobile arm aligned along the cube to the ulnar process and the fixed arm will be perpendicular to the ground. The unit of measure is the degrees; where to greater graduation, greater mobility. The normative range of shoulder mobility is 0º-90º in external rotation.
Screening visit, within the first seven days after treatment and after one month follow-up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline throwing speed after treatment and at month
Time Frame: Screening visit, within the first seven days after treatment and after one month follow-up visit
A "Doppler Radar Gun" device (Stalker Radar model) will be used to measure the speed of the throws. The unit of measure is in kilometers per hour; The higher the registered number, the faster the launch. The pitcher will be placed at the same distance at which he normally throws. The pitcher will be asked to make the throws at his maximum effort and the time that elapses from the release of the ball until the catcher catches it will be calculated.
Screening visit, within the first seven days after treatment and after one month follow-up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 2, 2020

Primary Completion (ACTUAL)

May 30, 2020

Study Completion (ACTUAL)

June 10, 2020

Study Registration Dates

First Submitted

February 25, 2020

First Submitted That Met QC Criteria

February 25, 2020

First Posted (ACTUAL)

February 26, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 5, 2021

Last Update Submitted That Met QC Criteria

September 1, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • BEIS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Baseball Pitcher

Clinical Trials on Weight implement

Subscribe